H2A histone family member X (H2AX, encoded by H2AFX ) and its C-terminal phosphorylation (c-H2AX) participates in the DNA damage response and mediates DNA repair [1] [2] [3] [4] [5] [6] . Hypoxia is a physiological stress that induces a replication-associated DNA damage response 7 . Moreover, hypoxia is the major driving force for neovascularization 8 , as the hypoxia-mediated induction of vascular growth factors triggers endothelial cell proliferation 8 . Here we studied the role of the hypoxia-induced DNA damage response in endothelial cell function and in hypoxia-driven neovascularization in vivo. Hypoxia induced replicationassociated generation of c-H2AX in endothelial cells in vitro and in mice. Both in cultured cells and in mice, endothelial cell proliferation under hypoxic conditions was reduced by H2AX deficiency. Whereas developmental angiogenesis was not affected in H2afx À/À mice, hypoxia-induced neovascularization during pathologic proliferative retinopathy, in response to hind limb ischemia or during tumor angiogenesis was substantially lower in H2afx À/À mice. Moreover, endothelial-specific H2afx deletion resulted in reduced hypoxia-driven retina neovascularization and tumor neovascularization. Our findings establish that H2AX, and hence activation of the DNA repair response, is needed for endothelial cells to maintain their proliferation under hypoxic conditions and is crucial for hypoxia-driven neovascularization.
H2A histone family member X (H2AX, encoded by H2AFX ) and its C-terminal phosphorylation (c-H2AX) participates in the DNA damage response and mediates DNA repair [1] [2] [3] [4] [5] [6] . Hypoxia is a physiological stress that induces a replication-associated DNA damage response 7 . Moreover, hypoxia is the major driving force for neovascularization 8 , as the hypoxia-mediated induction of vascular growth factors triggers endothelial cell proliferation 8 . Here we studied the role of the hypoxia-induced DNA damage response in endothelial cell function and in hypoxia-driven neovascularization in vivo. Hypoxia induced replicationassociated generation of c-H2AX in endothelial cells in vitro and in mice. Both in cultured cells and in mice, endothelial cell proliferation under hypoxic conditions was reduced by H2AX deficiency. Whereas developmental angiogenesis was not affected in H2afx À/À mice, hypoxia-induced neovascularization during pathologic proliferative retinopathy, in response to hind limb ischemia or during tumor angiogenesis was substantially lower in H2afx À/À mice. Moreover, endothelial-specific H2afx deletion resulted in reduced hypoxia-driven retina neovascularization and tumor neovascularization. Our findings establish that H2AX, and hence activation of the DNA repair response, is needed for endothelial cells to maintain their proliferation under hypoxic conditions and is crucial for hypoxia-driven neovascularization.
Upon DNA damage induction in cells, histone H2AX is rapidly phosphorylated at a conserved serine-glutamine motif in its carboxy terminus (amino acid residues 139 and 140) 3 . H2AX can mediate DNA repair by maintaining repair and signaling factors in proximity to the DNA damage site [3] [4] [5] [6] . The kinases orchestrating the DNA damage response include ataxia teleangiectasia mutated kinase (ATM), ATM-and Rad3-related kinase (ATR) and DNA-dependent protein kinase 2, 3, 9, 10 . These signaling pathways can be activated by ionizing radiation or by replication-associated stresses, such as hydroxyurea or aphidicolin 7, 11, 12 . Hypoxia also induces a type of replication stress. Previous studies have suggested that hypoxia, although not necessarily inducing DNA damage to cells, can induce a DNA damage response, including the activation of the ATR pathway, the ATM pathway or both, as well as the phosphorylation of H2AX [13] [14] [15] .
Hypoxia is the major trigger of neovascularization. Upon hypoxia, stabilization of the hypoxia-inducible transcription factor results in the upregulation of a large number of genes, including vascular endothelial growth factor, thereby stimulating neovascularizationrelated endothelial cell functions such as proliferation and sprouting 8 . Although vessel formation is essential for normal development, hypoxia-induced neovascularization in adults can also be triggered by pathological conditions 8 . This neovascularization response may be insufficient, as in ischemic disease, or excessive, as in proliferative retinopathies, including the retinopathy of prematurity (ROP) 8, 16 . In ROP, the retinal hypoxia associated with reduced vascularization after premature birth induces exorbitant abnormal vessel growth that may result in complications such as hemorrhages and even blindness 17 .
During the initial steps of hypoxia-induced neovascularization, endothelial cells are subject to hypoxia 8, 18 . Hypoxia can induce replication arrest in tumor cells and other cell types 7 , yet endothelial cells proliferate in response to hypoxia. Thus, we reasoned that an efficient DNA repair response in endothelial cells may be a prerequisite for their proliferation and for neovascularization under hypoxic conditions.
To examine the DNA repair response to hypoxia in endothelial cells, we exploited H2AX, as g-phosphorylation of H2AX at Ser139 is a very sensitive marker of the DNA damage response [3] [4] [5] [6] , and a previous study has shown g-H2AX induction in tumor cells by hypoxia 13 . Moreover, H2AX can mediate DNA repair [3] [4] [5] ; thus, H2AX-deficient cells and mice 4, 19 provide excellent tools to functionally address the role of DNA repair pathways in hypoxia-induced angiogenesis.
Hypoxia treatment induced distinct g-H2AX foci in primary cultures of human umbilical vein endothelial cells (HUVECs; Fig. 1a ). For comparison, we also subjected endothelial cells to lowgrade irradiation (2 Gy), which causes double-stranded DNA breaks, or treated them with hydroxyurea, which induces replicationassociated DNA damage (Fig. 1a) . Whereas irradiation induced g-H2AX in all endothelial cells, hypoxia treatment induced a phenotype similar to that induced by hydroxyurea, in that it resulted in g-H2AX formation only in a subpopulation of cells (Fig. 1a) . The percentages of cells showing g-H2AX foci were 3.1 ± 0.5%, 99.1 ± 0.4%, 19.1 ± 1.2%, 10.9 ± 0.7% and 17.1 ± 1.2% for normoxic, irradiated, hydroxyurea-treated, 1-h hypoxia-treated or 6-h hypoxia-treated cells, respectively (means ± s.e.m.). Western blot analysis confirmed the generation of g-H2AX in HUVECs upon hypoxia treatment ( Supplementary Fig. 1 online) . Hypoxiainduced g-H2AX foci were predominantly present in proliferating endothelial cells that stained positive for proliferative cell nuclear antigen 20 ( Supplementary Fig. 2 online) and colocalized with replication protein A 21 ( Supplementary Fig. 3 online), suggesting a replication stress-associated generation of g-H2AX by hypoxia. We then determined which of the two major DNA repair signaling pathways, the ATM pathway or the ATR pathway, was involved in the generation of g-H2AX in endothelial cells during hypoxia. Small interfering RNA (siRNA)-mediated knockdown of ATR, but not of ATM, prevented hypoxia-dependent g-H2AX production (Fig. 1b,c) . We obtained similar results when we used other ATR-specific siRNAs (data not shown). That ATM is not involved in the hypoxia-induced response in HUVECs was supported by the absence of ATM phosphorylation at Ser1981, a marker of ATM activation 9 , after hypoxia treatment (data not shown). These data suggest that hypoxia induces replication stress-associated g-H2AX generation in endothelial cells in an ATR-dependent manner.
We next addressed the functional importance of the DNA repair response for endothelial cell proliferation and hypoxia-induced neovascularization. We studied the effect of loss of H2AX on endothelial cell proliferation, either in HUVECs by comparing the effects of H2AX-targeted and control siRNA (Fig. 1d) or in primary mouse endothelial cells by comparing cells isolated from H2afx +/+ and H2afx À/À mice. In HUVECs, H2AX downregulation induced a marginal reduction in fibroblast growth factor-2 (FGF-2)-or fetal calf serum (FCS)-induced cell proliferation under normoxia (Fig. 1e) . Notably, H2AX downregulation significantly decreased growth factorinduced and FCS-induced HUVEC proliferation under hypoxic conditions (Fig. 1e) . We observed similar results using H2AX-deficient primary mouse endothelial cell cultures (Fig. 1f) . In contrast, other proangiogenic functions of endothelial cells, such as extracellular matrix-dependent tube formation, were not affected by the absence of H2AX ( Supplementary Fig. 4 online) . These data indicate a crucial role for H2AX in maintaining endothelial cell proliferation under hypoxic conditions. These findings point to a role of H2AX in hypoxia-driven neovascularization. We investigated this hypothesis in vivo using a mouse model of ROP in which hypoxia induces retinal neovascularization 17, 22, 23 . In the ROP model, postnatal day 7 (P7) pups are incubated in 75% oxygen for 5 d, which induces regression and obliteration in the developing retina vasculature. This results in a massive retinal hypoxia after P12, when pups are transferred to normal oxygen, leading to increased endothelial cell proliferation and pathological exuberant neovascularization (proliferative retinopathy) 17, 22, 23 . In pups subjected to the ROP protocol, we found increased amounts of g-H2AX during the hypoxia phase (P13-P15) compared to control mice kept under normoxic conditions ( Supplementary Fig. 5a online). Immunostaining indicated that this increase was, at least in part, due to g-H2AX generation in endothelial cells, with little g-H2AX staining associated with vascular nuclei in the developing vasculature of control pups that were kept under normoxic conditions (Fig. 1g) . Induction of g-H2AX in retinas of mice subjected to the ROP protocol was evident predominantly in the nuclei of proliferating retinal vascular endothelial cells, including endothelial nuclei in pathological neovascular tufts ( Supplementary Fig. 5b ). Thus, hypoxia induces generation of g-H2AX in the retinal vasculature in vivo. We next studied the effect of H2AX deficiency on normal development of the retinal vasculature (between days P1 and P20) and on hypoxia-induced neovascularization in the ROP model. Consistent with low levels of g-H2AX in the developing retinal vasculature (Fig. 1g) , we observed no difference between wild-type (WT) and H2afx À/À mice when we analyzed retinal vascular development at days P5, P10 and P15 ( Supplementary Fig. 6 online) . We then compared hypoxia-induced retinal neovascularization at P17 in WT and H2afx À/À mice subjected to the ROP protocol. We observed a significant (P o 0.05) decrease in hypoxia-driven retinal neovascularization in H2afx À/À mice (Fig. 2a) . Immunohistochemical analysis of retinal sections revealed a 50% reduction in the extent of pathological neovascularization in H2afx À/À mice (Fig. 2a,b) . We observed fewer pathological neovascular tufts and a more extensive physiological vasculature in retina whole mounts from H2afx À/À mice as compared to WT mice (Fig. 2c,d ). This decrease in pathological retinal neovascularization was accompanied by a decrease in endothelial cell proliferation and an increase in endothelial cell apoptosis (Fig. 2d-f) .
To test the role of endothelial H2AX in hypoxia-driven pathological angiogenesis and exclude the possibility that systemic H2AX deficiency could account for the observed phenotype, we generated endothelialspecific H2AX-deficient mice using the vascular-endothelial (VE)-cadherin-Cre system 24 and H2afx-floxed mice 25 . In particular, we crossed H2afx flox/flox mice with H2afx +/À mice that expressed the Cre recombinase under the control of the VE-cadherin promoter (VECCre + ) to generate VEC-Cre + H2afx flox/À mice (endothelial-specific H2AX-deficient) and VEC-Cre À H2afx flox/À mice (H2AX-sufficient). Endothelial-specific H2AX-deficient mice showed significantly less neovascularization as compared to H2AX-sufficient mice ( Fig. 2g and Supplementary Fig. 7 online) . These findings indicate that endothelial H2AX is dispensable during normal vascular development but is functional in the context of hypoxia-driven retinal angiogenesis.
We next studied the role of H2AX in the hind limb ischemia model, in which neovascularization is induced by acute disruption of blood supply to the hind limb and consequent tissue ischemia and hypoxia 26 . Consistent with the findings from the ROP model, 
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NATURE MEDICINE VOLUME 15 [ NUMBER 5 [ MAY 2009 in the hind limb ischemia model (Fig. 3a) . Whereas the WT group recovered to 96.6% and 70.7% of normal blood flow at days 14 and 21, respectively, the H2afx À/À group recovered to only 48% and 42.9% on these days (Fig. 3a) . In addition, we found a reduction in endothelial cell proliferation in the ischemic muscles of H2afx À/À mice as compared to WT mice (Fig. 3b,c) .
To provide further evidence for the specific function of H2AX in hypoxia-driven neovascularization as opposed to neovascularization under normoxic conditions, we studied hypoxia-driven tumor neovascularization and growth factor-induced neovascularization. After injecting Lewis lung carcinoma cells subcutaneously in WT and H2afx À/À mice, we assessed tumor angiogenesis by staining tumor sections for the endothelial-specific marker CD31. We observed a significant decrease in vascular density at two different time points (days 21 and 25 after tumor implantation) in tumors implanted into H2afx À/À mice (Fig. 4a,b) . In addition, we found decreased endothelial cell proliferation and increased endothelial cell apoptosis in tumors implanted into H2afx À/À mice (Fig. 4c,d ). Pericyte coverage (NG-2-positive cells) of vessels was similar in tumor vessels of WT and H2afx À/À mice (Fig. 4e) , suggesting that H2AX deficiency leads to reduced tumor angiogenesis predominantly by affecting endothelial cell proliferation rather than vessel maturation. Associated with impaired tumor angiogenesis, both the growth and the final weight of tumors were significantly reduced in H2afx À/À mice (Fig. 4f,g ). To investigate the role of endothelial H2AX in tumor angiogenesis, we implanted tumors into endothelial-specific H2AX-deficient mice and littermate H2AX-sufficient mice. Tumors implanted into endothelialspecific H2AX-deficient mice showed significantly (P o 0.01) less neovascularization as compared to tumors implanted into H2AX-sufficient mice ( Supplementary Fig. 8a online) . In addition, tumor growth was significantly (P o 0.05) decreased in endothelial-specific H2AX-deficient mice ( Supplementary Fig. 8b ). These data indicate that endothelial H2AX has a role in hypoxia-driven tumor angiogenesis. In contrast to tumor angiogenesis, angiogenesis induced by FGF-2 in Matrigel plugs injected into WT or H2afx À/À mice was not affected by H2AX deficiency ( Supplementary Fig. 9 online) .
Here we have found that hypoxia-triggered neovascularization requires the function of H2AX in endothelial cells. Phosphorylation of H2AX was induced by hypoxia in proliferating endothelial cells in vitro and in the mouse retina in vivo, in accordance with previous observations that hypoxia induces a replication stress-associated DNA repair response in other cell types 7, 13, 27 . The hypoxia-induced DNA repair response may not be the result of induction of DNA damage by hypoxia itself. Low levels of DNA damage occur during replication, and hypoxia-induced replication stress may result in accumulation of this damage 28 . Alternatively, hypoxia has been proposed as a direct inducer of DNA damage by repressing genes crucial to DNA repair 29, 30 . Irrespective of the mechanism responsible, we showed that hypoxia-induced activation of g-H2AX and an intact DNA repair response in endothelial cells are of particular importance during hypoxia-driven pathological neovascularization. Loss of H2AX in endothelial cells markedly compromises endothelial cell proliferation under hypoxia but only marginally under normoxia. Moreover, hypoxia-induced neovascularization during pathologic proliferative retinopathy, in response to hind limb ischemia or during tumor growth was significantly reduced by H2AX deficiency, whereas physiological developmental vascularization was not affected. Our findings point to the possibility that vascular-targeted inhibitors of H2AX may provide a new strategy for preventing hypoxia-induced pathological neovascularization in conditions such as in tumor growth, ROP or diabetic retinopathy 16, 17 .
METHODS
Mice and hypoxia-induced retinal vascularization. Mouse studies were approved by the US National Cancer Institute Animal Care and Use Committee. H2afx À/À mice have been previously described 19 . Littermate H2afx -/À or H2afx +/+ mice were used in the ROP model that was induced as previously described by us and others 22, 23, 31 . At day P17, we killed the mice and processed their eyes for quantification of preretinal neovascular nuclei, as previously described 22, 23 . Briefly, we stained 6-mm paraffin-embedded serial sections with periodic acid Schiff and evaluated ten intact sections of equal length, each 18 mm apart. We counted all retinal vascular cell nuclei anterior to the internal limiting membrane in each section. We calculated the mean number of the neovascular nuclei from ten counted sections. We did not observe any neovascular cell nuclei anterior to the internal limiting membrane in normal mice kept under normoxic conditions. Moreover, we obtained WT C57BL/6 mice from Charles River and subjected them to the ROP protocol or kept them under normoxic conditions, and we used their retinas for analysis of H2AX phosphorylation, as described in the Supplementary Methods online.
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In addition, we subjected endothelial-specific H2AX-deficient and H2AX-sufficient mice to the ROP protocol. H2afx flox/flox mice have been previously described 25 . To induce deletion of H2afx in endothelial cells, we crossed H2afx flox/flox mice (kindly provided by F. Alt) with H2afx +/À mice that also carried a gene construct in which expression of the Cre recombinase is under the control of the promoter of the gene encoding VE-cadherin 24 (VEC-Cre + ) to generate VEC-Cre + H2afx flox/À mice (endothelial-specific H2AX-deficient) and VEC-Cre À H2afx flox/À mice (H2AX-sufficient, used as littermate controls). We purchased VEC-Cre + mice from the Jackson Laboratory. We assessed the efficiency of Cre-mediated excision in vascular endothelial cells by immunohistochemistry analysis ( Supplementary Fig. 7 ). Briefly, we froze and sectioned eyes from endothelial-specific H2AX-deficient or H2AX-sufficient mice. We fixed the sections in ice-cold acetone for 10 min, washed them with PBS, blocked them with PBS containing 1% BSA, 5% goat serum (Sigma-Aldrich) and 0.1% Triton-X 100 (Fluka), and incubated them with a rabbit antibody specific for total H2AX (1 in 100, Novus) at 4 1C overnight. After washing the sections with PBS, we further incubated them with an AlexaFluor 568-conjugated goat antibody to rabbit IgG (Invitrogen), with FITC-conjugated Bandeirea simplicifolia isolectin B4 (Sigma-Aldrich) to visualize vessels, and with DAPI. We obtained the images with a Zeiss laser-scanning confocal microscope.
Retina whole mounts. We used a previously published protocol to prepare retina whole mounts 22, 32 . Briefly, after subjecting mice to the ROP protocol, we injected them intraperitoneally at day P16 with BrdU and killed them at day P17. We enucleated the eyes and fixed them at 4 1C overnight. After extraction and washing of the retinas, we permeabilized them at 4 1C overnight and stained them with FITC-conjugated B. Simplicifolia isolectin B4. We further stained some retinas for BrdU. We subjected these retinas to antigen retrieval with 6N HCl and 0.1% Triton-X 100, followed by blocking with PBS containing 1% BSA, 5% goat serum and incubation with a biotinylated BrdU-specific antibody (1 in 10, BD Biosciences). We detected BrdU-specific antibody with AlexaFluor 568-conjugated streptavidin at 4 1C for 6 h. Finally, we flatmounted the retinas and applied a cover slip. We obtained images with a Zeiss laser-scanning confocal microscope and a Zeiss Axiovert 200M with Axiovision 4.6 software.
Tumor angiogenesis. We followed a previously described protocol for tumor growth and angiogenesis 33 . We subcutaneously injected Lewis lung carcinoma cells (1 Â 10 6 ) at two sites in the backs of littermate H2afx À/À or WT mice or into the backs of endothelial-specific H2AX-deficient or H2AX-sufficient mice. We determined tumor volume and tumor weight after tumor excision as previously described 33 . At each time point, we excised and fixed the implanted tumors in 4% paraformaldehyde solution for 1 h at 4 1C and incubated them in 15% and 30% sucrose for 16 and 24 h, respectively. We sectioned the tissues (8-mm thick sections), blocked the slides with 5% goat serum in 1% BSA and 0.1% Triton-X 100 in PBS for 1 h at 22 1C and stained them with a rat CD31-specific primary antibody (BD Biosciences) overnight at 4 1C. After washing the sections with PBS, we probed them with an AlexaFluor 568-conjugated goat antibody to rat IgG (Invitrogen). We assessed tumor vascularity by counting CD31-positive vessels in six to ten sections per tumor.
To assess vessel proliferation, we stained day 25 tumor sections for BrdU using the in situ BrdU kit (BD Biosciences) as described in the Supplementary Methods, and to visualize vessels we stained for CD31. We counted BrdUpositive vascular nuclei in two random fields per section from six different sections per tumor. We assessed apoptosis in the vessels of tumors implanted in WT or H2afx À/À mice by staining for CD31 and cleaved caspase-3: we processed tumors as described in the previous paragraph and incubated sections with a rabbit antibody against mouse cleaved caspase-3 (1 in 300, Cell Signaling Technology) and with a rat CD31-specific antibody overnight at 4 1C. We detected primary antibodies using fluorescently labeled secondary antibodies specific for rabbit and rat IgG (Invitrogen). We counted the cleaved caspase-3-positive endothelial cells in three random fields per section from six different sections per tumor.
To visualize pericyte coverage of the tumor vessels in tumors implanted in H2afx À/À and H2afx +/+ mice, we used double staining of CD31 and NG2. We stained 10-mm sections for CD31 as described above, and we also incubated them with a rabbit antibody to NG2 (1 in 100, Millipore) at 4 1C overnight. We detected primary antibodies using fluorescently labeled secondary antibodies specific for rabbit and rat IgG. We counted NG-2-positive cells covering blood vessels in four different sections per tumor.
Additional methodology. Detailed methods for endothelial cell culture and transfections, in vitro immunofluorescence, western blotting, in vitro endothelial cell proliferation assay, mouse hind limb ischemic surgery, endothelial cell proliferation and apoptosis in the retina in vivo, retina digestion and immunofluorescence, physiological developmental retinal angiogenesis, in vitro Matrigel tube formation assay and in vivo Matrigel assay are described in the Supplementary Methods.
Note: Supplementary information is available on the Nature Medicine website.
